Colombia vs Mexico: HIV-positive TB patients on ART (antiretroviral therapy)
Colombia
68.0%
in 2024
Mexico
66.0%
in 2023
Colombia rank
130th
Mexico rank
132nd
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Colombia
- Mexico
How they compare
Colombia currently reports 68.0% against 66.0% in Mexico, a difference of 2.0%.
The two have swapped places 7 times across 16 shared years of data; in 2007 it was Colombia ahead.
Colombia ranks 130th and Mexico ranks 132nd of 144 countries.
Across the 3 decades both report, Colombia averaged higher in 1 and Mexico in 2.
Head to head by decade
| Decade | Colombia | Mexico | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 60.5% | 20.0% | 40.5% | Colombia |
| 2010s | 50.5% | 57.6% | 7.1% | Mexico |
| 2020s | 57.8% | 64.8% | 7.0% | Mexico |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Colombia or Mexico?
- Colombia, at 68.0% against 66.0% in Mexico as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Colombia and Mexico?
- 2.0%, with Colombia ahead.
- How many years of comparable data are there for Colombia and Mexico?
- 16 years are reported by both, from 2007 to 2023.
- How do Colombia and Mexico rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Colombia ranks 130th and Mexico ranks 132nd of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.